Vinod Khosla is a venture capitalist and the founder of Khosla Ventures, a Menlo Park firm that has invested across the AI sector, including an early stake in OpenAI. In AI policy he features less as a lobbyist than as an investor whose portfolio spans several of the areas the field tracks and who states strong public positions on AI's capacity to replace professional judgment, particularly in medicine.
Investment activity
Khosla Ventures appears repeatedly in the financing record of AI startups tracked here. It co-led the $133.7 million seed round for General Intuition in October 2025 alongside General Catalyst, one of the larger seed financings of that year (Source: techcrunch.com). It backs PrismML, the Caltech spin-off working on extreme model compression for on-device inference, which raised a $16.25 million seed round in early 2026 (Source: theinformation.com). It is named among earlier and returning investors in Physical Intelligence (Source: therobotreport.com).
In August 2026 the firm invested alongside Alphabet and Radical Ventures in Discovery Loop, the public benefit corporation founded by Jeff Dean, Sanjay Ghemawat, Oriol Vinyals and Quoc Le on their departure from Google. Khosla met the four at his Sand Hill Road office on a Saturday in order to conceal the departures, and called them "the ultimate superstar team" (Source: implicator.ai).
Position on autonomous medical AI
Khosla is a co-author, with Ezekiel J. Emanuel, Abe Baker-Butler and Neal Khosla, of a Perspective published in the Journal of the American Medical Association on August 17, 2026, "Will Autonomous AI Exceed AI-Aided Physicians as the Best Medical Care?" (doi:10.1001/jama.2026.15380). The piece argues that autonomous AI alone, rather than a hybrid model in which physicians consult well-trained systems, can deliver the best patient outcomes, setting itself against the American Medical Association's framing of AI as "augmented intelligence" and the American College of Physicians' position that AI "should be limited to a supportive role in clinical decision-making." Khosla's byline carries the Khosla Ventures affiliation; Neal Khosla's is Curai Health, a company in the same field (Source: jamanetwork.com). The body of the Perspective is paywalled and its full argument is not established here. A reader questioned the paper's conflict-of-interest disclosures and the quality of the studies it cites (Source: wired.com). See AI in Healthcare.
Other public positions
Khosla was among the industry and investment signatories to the "We Must Act Now" statement (We Must Act Now: A Statement on AI's Transformation of the Economy (July 2026)). During the November 2023 OpenAI board crisis he criticised the board, saying its members' "religion of 'effective altruism' and its misapplication could have set back the world's path to the tremendous benefits of artificial intelligence" (How a Fervent Belief Split Silicon Valley—and Fueled the Blowup at OpenAI — Robert McMillan, Deepa Seetharaman (WSJ, November 22 2023)).
Relationships
- related: AI in Healthcare — the autonomous-versus-augmented care argument.
- related: OpenAI, Discovery Loop, General Intuition, PrismML, Physical Intelligence — portfolio and investment record.
- related: We Must Act Now: A Statement on AI's Transformation of the Economy (July 2026), How a Fervent Belief Split Silicon Valley—and Fueled the Blowup at OpenAI — Robert McMillan, Deepa Seetharaman (WSJ, November 22 2023) — signed statement and quoted position.
- related: Effective Altruism — the movement his 2023 criticism targets.